HFCAS OpenIR

浏览/检索结果: 共3条,第1-3条 帮助

已选(0)清除 条数/页:   排序方式:
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili;  Zou, Dehui;  Lv, Fangfang;  Guo, Wei;  Liu, Aichun;  Li, Caixia;  Tan, Ziwen;  Liu, Yang;  Fu, Lina;  Guo, Haiyi;  Novotny, William;  Huang, Jane;  Li, Yufu
收藏  |  浏览/下载:34/0  |  提交时间:2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng;  Zou, Dehui;  Li, Wei;  Yang, Haiyan;  Liu, Ting;  Wang, Quanshun;  Lv, Fangfang;  Guo, Haiyi;  Zhao, Xia;  Wang, Dan;  Zhang, Pei;  Wang, Yidi;  Wang, Lei;  Liu, Tengfei;  Zhang, Yun;  Shen, Zhirong;  Huang, Jane;  Zhu, Jun
收藏  |  浏览/下载:44/0  |  提交时间:2022/05/05
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng;  Zou, Dehui;  Li, Wei;  Yang, Haiyan;  Liu, Ting;  Wang, Quanshun;  Lv, Fangfang;  Guo, Haiyi;  Yang, Liudi;  Huang, Jane;  Novotny, William F.;  Wang, Yidi;  Zhu, Jun
收藏  |  浏览/下载:56/0  |  提交时间:2022/01/10